EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 214
Summary
- Conditions
- Locally Advanced Pancreatic Cancer
- Metastatic Pancreas Cancer
- Pancreatic Adenocarcinoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03126435
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Li-Tzong Chen, M.D., Ph.D. National Cheng Kung University Hospital,Tainan, Taiwan, R.O.C
Get Well Soon